✦ LIBER ✦

Poster Abstract #17: Double-Blind Randomized Treatment of Poststroke Depression With Nefiracetam

✍ Scribed by Robert G. Robinson; Ricardo E. Jorge; Sergio E. Starkstein

Book ID: 116800729
Publisher: Springer-Verlag
Year: 2007
Tongue: English
Weight: 38 KB
Volume: 4
Category: Article
ISSN: 1933-7213
DOI: 10.1016/j.nurt.2007.03.021

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomized, double-blind comparison of

A randomized, double-blind comparison of duloxetine and venlafaxine in the treatment of patients with major depressive disorder

✍ David G.S. Perahia; Yili Lu Pritchett; Daniel K. Kajdasz; Michael Bauer; Rakesh 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 429 KB

A Randomized and double-blinded clinical

A Randomized and double-blinded clinical trial of Venlafaxine HCL sustained release capsules for treatment in adolescents with major depression

✍ W.D. Ji; H.F. Chang; S.C.H. Yang; C.H. Yang; X.Q. Huang; J.X. Zhou; T.Y. Guo 📂 Article 📅 2008 🏛 Elsevier Science 🌐 French ⚖ 43 KB

A randomized, double-blind, placebo-cont

A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder

✍ Lesley M. Arnold; Amy Rosen; Yili Lu Pritchett; Deborah N. D'Souza; David J. Gol 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 265 KB

St. John’s wort extract LI160 for the tr

St. John’s wort extract LI160 for the treatment of depression with atypical features – A double-blind, randomized, and placebo-controlled trial

✍ Marcus Mannel; Ulrike Kuhn; Ulrich Schmidt; Michael Ploch; Harald Murck 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 322 KB

A double blind, randomized clinical tria

A double blind, randomized clinical trial assessing the efficacy and safety of augmenting standard antidepressant therapy with nimodipine in the treatment of ‘vascular depression’

✍ Fernando E. Taragano; Ricardo Allegri; Augusto Vicario; Pablo Bagnatti; Constant 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB 👁 1 views

## Abstract ## Background ‘Vascular depression’ may be caused by cerebrovascular disease. Calcium channel blockers, which are putative treatments for cerebrovascular disease, might be expected to improve depression reduction and to prevent recurrence of depression in this patient population. This

Poster 149: Preliminary Results of a Nov

Poster 149: Preliminary Results of a Novel Method for the Treatment of Chronic Plantar Fasciitis With Botulinum Toxin Type A: A Randomized, Double-Blind Study

✍ Mehul Desai; Thomas Heckman; Joseph Hidler; Nara Pravat; Mohsin S. Sheikh; Curti 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 44 KB